Shares of G1 Therapeutics plunged 46% after disappointing results from their Phase 3 trilaciclib combination trial for triple-negative breast cancer. ...
Cidara Therapeutics receives $11.1 million milestone payment from Mundipharma for European approval of new antifungal drug, Rezzayo. Analysts see potential ...
Tango Therapeutics receives positive coverage from Piper Sandler, emphasizing its strong position in precision oncology. The firm believes the company's ...